Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RBS-2418 by Riboscience for Pancreatic Cancer: Likelihood of Approval
RBS-2418 is under clinical development by Riboscience and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I...